✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Hugel Inc

Common Name
Hugel
Country
South Korea
Sector
Healthcare
Industry
Biotechnology
Employees
594
Ticker
145020
Exchange
Korea Exchange
Description
Hugel Inc. is a biopharmaceutical company known for its specialization in the development and commercialization of botulinum toxin-related products and other aesthetic medicine solutions. Leveraging i...

Hugel's Revenues Data

Explore Hugel's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
294,388,664a
₩425,110 million
254,224,768a
₩373,047 million
250,187,784a
₩319,700 million
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Hugel’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Hugel's Annual Report 2025